Literature DB >> 17041621

Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?

M N Corradetti1, K-L Guan.   

Abstract

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that controls many aspects of cellular physiology, including transcription, translation, cell size, cytoskeletal organization and autophagy. Recent advances in the mTOR signaling field have found that mTOR exists in two heteromeric complexes, mTORC1 and mTORC2. The activity of mTORC1 is regulated by the integration of many signals, including growth factors, insulin, nutrients, energy availability and cellular stressors such as hypoxia, osmotic stress, reactive oxygen species and viral infection. In this review we highlight recent advances in the mTOR signaling field that relate to how the two mTOR complexes are regulated, and we discuss stress conditions linked to the mTOR signaling network that have not been extensively covered in other reviews. Given the diversity of signals that have been shown to impinge on mTOR, we also speculate on other signal-transduction pathways that may be linked to mTOR in the future.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041621     DOI: 10.1038/sj.onc.1209885

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  158 in total

1.  Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis.

Authors:  Jeske J Smink; Per-Ulf Tunn; Achim Leutz
Journal:  J Mol Med (Berl)       Date:  2011-11-10       Impact factor: 4.599

2.  Role of inositol trisphosphate receptors in autophagy in DT40 cells.

Authors:  M Tariq Khan; Suresh K Joseph
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

3.  The abundance and activation of mTORC1 regulators in skeletal muscle of neonatal pigs are modulated by insulin, amino acids, and age.

Authors:  Agus Suryawan; Teresa A Davis
Journal:  J Appl Physiol (1985)       Date:  2010-08-19

Review 4.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

5.  Suppression of autophagy enhanced growth inhibition and apoptosis of interferon-β in human glioma cells.

Authors:  Yubin Li; Haiyan Zhu; Xian Zeng; Jiajun Fan; Xiaolu Qian; Shaofei Wang; Ziyu Wang; Yun Sun; Xiaodan Wang; Weiwu Wang; Dianwen Ju
Journal:  Mol Neurobiol       Date:  2013-01-18       Impact factor: 5.590

6.  Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein.

Authors:  Tatsuhiro Sato; Akio Nakashima; Lea Guo; Fuyuhiko Tamanoi
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

Review 7.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

8.  Activation of mTORC1 signaling pathway in AIDS-related lymphomas.

Authors:  Mouna El-Salem; Puthiyaveettil N Raghunath; Michal Marzec; Xiaobin Liu; Monika Kasprzycka; Erle Robertson; Mariusz A Wasik
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

Review 9.  Life in the midst of scarcity: adaptations to nutrient availability in Saccharomyces cerevisiae.

Authors:  Bart Smets; Ruben Ghillebert; Pepijn De Snijder; Matteo Binda; Erwin Swinnen; Claudio De Virgilio; Joris Winderickx
Journal:  Curr Genet       Date:  2010-02       Impact factor: 3.886

Review 10.  Mitochondrial metabolic reprogramming induced by calorie restriction.

Authors:  Alejandro Martin-Montalvo; Rafael de Cabo
Journal:  Antioxid Redox Signal       Date:  2012-10-15       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.